10x Genomics

Recent news

• Rating change
  BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $30
  Market Newswire · 2026/5/8
• Rating change
  J.P. Morgan Remains a Hold on 10x Genomics (TXG)
  TipRanks · 2026/8/11
• Rating change
  Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $45
  Market Newswire · 2026/7/8
• Rating change
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $30 to $32
  Market Newswire · 2026/4/21
• Rating change
  Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/5/8
• Rating change
  Morgan Stanley Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $20.5
  Market Newswire · 2026/5/12
• Rating change
  Piper Sandler Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $42
  Market Newswire · 2026/7/1
• Citi Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $50
  Market Newswire · 2026/8/7
• Rating change
  CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $50
  Market Newswire · 2026/7/14
• RBC Capital Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $70
  Market Newswire · 2026/9/1
• CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $60
  Market Newswire · 2026/8/10
• Rating change
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $23 to $32
  Market Newswire · 2026/5/9
• William Blair Maintains 10x Genomics(TXG.US) With Buy Rating
  Market Newswire · 2026/9/30
• Rating change
  TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $47
  Market Newswire · 2026/7/15
• Rating change
  A Quick Look at Today's Ratings for 10x Genomics(TXG.US), With a Forecast Between $50 to $53
  Market Newswire · 2026/8/8
• Rating change
  TD Cowen Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $25
  Market Newswire · 2026/5/8
• Rating change
  CCORF Maintains 10x Genomics(TXG.US) With Buy Rating, Maintains Target Price $32
  Market Newswire · 2026/6/10
• Rating change
  Barclays Maintains 10x Genomics(TXG.US) With Buy Rating, Raises Target Price to $40
  Market Newswire · 2026/6/24
• Rating change
  BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating
  Market Newswire · 2026/5/14
• Leerink Partners Maintains 10x Genomics(TXG.US) With Hold Rating, Raises Target Price to $90
  Market Newswire · 2026/9/29

Headlines are aggregated automatically and are not independently verified or edited by our team.